Onconetix, Inc.
ONCO · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $1 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | -$0 | $1 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 4,217.3% | – | – | – |
| Gross Profit | $0 | -$0 | -$0 | -$0 |
| % Margin | 41.8% | -1,927.9% | – | – |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -2,281.9% | -62,784.1% | – | – |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -2,325.2% | -63,986.5% | – | – |
| EPS Diluted | -1,823.25 | -87.6 | -1.09 | -0.31 |
| % Growth | -1,981.3% | -7,936.7% | -251.6% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |